8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-24-065371
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading dnth-20240523.htm…